Vnda stock price target
Expensive Market, What To Buy? Vanda Pharmaceuticals Inc ... Mar 11, 2020 · That day the Stifel set price target on the stock to $17. Cantor Fitzgerald was of a view that VNDA is Overweight in its latest report on December 04, 2018. Jefferies thinks that VNDA is worth Buy rating. This was contained in the firm’s report on December 04, 2018 in which the stock’s price target was also moved to 40. VNDA | Vanda Pharmaceuticals Inc. Analyst Estimates ... VNDA updated stock price target summary. Dow Jones, a News Corp company. News Corp is a network of leading companies in the worlds of diversified media, news, education, and information services.
Securities products and services offered to self-directed investors through ST Invest, LLC. Member FINRA / SIPC.ST Invest is a wholly owned subsidiary of StockTwits, Inc. Investing in securities products involves risk, including possible loss of principal. Please read important legal disclosures.
Find the latest Vanda Pharmaceuticals Inc. (VNDA) stock quote, history, news and other vital information to help you with your stock trading and investing. Vanda Pharmaceuticals Inc. (VNDA) Latest Stock News ... Get the latest Vanda Pharmaceuticals Inc. (VNDA) stock news and headlines to help you in your trading and investing decisions. Raising target price to $10.00. Lowering target price to $8.00 VNDA Stock Quote - Vanda Pharmaceuticals Inc. Common Stock ... Mar 27, 2020 · Stock quote for Vanda Pharmaceuticals Inc. Common Stock Common Stock (VNDA) with real-time last sale and extended hours stock prices, company news, charts, and research at Nasdaq. VNDA Stock Price and Chart — NASDAQ:VNDA — TradingView View live VANDA PHARMACE INC chart to track its stock's price action. Find market predictions, VNDA financials and market news. View live VANDA PHARMACE INC chart to track its stock's price action. Find market predictions, VNDA financials and market news. Second wave downward move imminent with RSI confirmation @ 35 and bearish $13 target
Mar 11, 2020 · That day the Stifel set price target on the stock to $17. Cantor Fitzgerald was of a view that VNDA is Overweight in its latest report on December 04, 2018. Jefferies thinks that VNDA is worth Buy rating. This was contained in the firm’s report on December 04, 2018 in which the stock’s price target was also moved to 40.
VNDA Description — Vanda Pharmaceuticals Inc 0.10%, $1,663,470. List of all 37 ETFs holding VNDA » 7 Stocks With Low Price-to-Sales Ratio for a Solid Portfolio A stock Forgotten S&P 500 Giants: Analysts' Current Least Favorites 4 days ago That day the Stifel set price target on the stock to $2. Citigroup also rated VNDA as Upgrade on March 12, 2020, with its price target of $14 Real time Vanda Pharmaceuticals (VNDA) stock price quote, stock graph, news & analysis. VNDA Stock Summary. With a price/earnings ratio of 4.1, Vanda Pharmaceuticals Inc P/E ratio is greater than that of about only 9.87% of stocks in our set with ©2020 StockTwits, Inc. All rights reserved. Market Data by Xignite and BATS BZX Real-Time Price. Securities products and services offered to self-directed Learn about VNDA with our data and independent analysis including price, star rating, valuation, dividends, and financials. Stock Strategist Industry Reports. Historical daily share price chart and data for Vanda Pharmaceuticals since 2020 adjusted for splits. The latest closing stock price for Vanda Pharmaceuticals as
4 days ago That day the Stifel set price target on the stock to $2. Citigroup also rated VNDA as Upgrade on March 12, 2020, with its price target of $14
Mar 27, 2020 · Stock quote for Vanda Pharmaceuticals Inc. Common Stock Common Stock (VNDA) with real-time last sale and extended hours stock prices, company news, charts, and research at Nasdaq. VNDA Stock Price and Chart — NASDAQ:VNDA — TradingView View live VANDA PHARMACE INC chart to track its stock's price action. Find market predictions, VNDA financials and market news. View live VANDA PHARMACE INC chart to track its stock's price action. Find market predictions, VNDA financials and market news. Second wave downward move imminent with RSI confirmation @ 35 and bearish $13 target Expensive Market, What To Buy? Vanda Pharmaceuticals Inc ... Mar 11, 2020 · That day the Stifel set price target on the stock to $17. Cantor Fitzgerald was of a view that VNDA is Overweight in its latest report on December 04, 2018. Jefferies thinks that VNDA is worth Buy rating. This was contained in the firm’s report on December 04, 2018 in which the stock’s price target was also moved to 40. VNDA | Vanda Pharmaceuticals Inc. Analyst Estimates ...
Vanda Pharmaceuticals Inc., VNDA Quick Chart - (NAS) VNDA ...
Vanda Pharma (VNDA) Stock Price Target Upped on Drug Patent Ruling. By Annie Palmer. Aug 26, 2016 3:58 PM EDT. MARKETS. Vanda Pharmaceuticals (VNDA) Stock Soars on Drug Patent Ruling.
Earnings estimates and surprises for Vanda Pharmaceuticals (VNDA) are an important tool used to evaluate the company's overall strength and value of the stock. when the actual earnings come in under the analysts' estimate, the stock's share price tends to fall. Detailed Earnings Estimates. Vanda Pharmaceuticals (NASDAQ:VNDA) Stock Rating Upgraded ... Shares of NASDAQ:VNDA opened at $16.18 on Friday. The stock has a market cap of $862.99 million, a P/E ratio of 33.71 and a beta of 0.35. The firm has a fifty day moving average price of $16.60 and a 200 day moving average price of $14.56. Vanda Pharmaceuticals has a 1 … VNDA - Research and Analysis for VANDA PHARMACEUTICALS … In-depth view of key statistics and finances for VANDA PHARMACEUTICALS INC. (VNDA) on MSN Money.